Guided Therapeutics Inc (GTHP): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2017-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Figures left out. The filed Shares Outstanding for the year ended 2019-12-31 is not shown: shares outstanding out of scale with net income per share. That usually means the filing tagged the figure in the wrong unit.

86.15M

As of 2025-12-31

96.54M

As of 2026-06-30

+21.0%

3-year compound annual growth

n/m

5-year compound annual growth

2010-12-31 Shares Outstanding (shares) 2025-12-31

Period ended	Shares Outstanding	Change YoY	Source filing
2025-12-31	86.15M	+32.3%	2026-03-31, Balance as of period end
2024-12-31	65.13M	+20.4%	2026-03-31, Balance as of period end
2023-12-31	54.10M	+11.3%	2025-03-31, Balance as of period end
2022-12-31	48.60M	+255.4%	2024-03-28, Balance as of period end
2021-12-31	13.67M	n/m	2023-03-30, Balance as of period end
2020-12-31	13.1K	n/c	2021-04-07, Balance as of period end
No annual figure between 2018-12-31 and 2020-12-31.
2018-12-31	2.7K	-95.7%	2020-04-20, Balance as of period end
2017-12-31	62.0K	n/c	2019-05-08, Balance as of period end
2016-12-31	669	n/m	2018-04-20, Balance as of period end
2015-12-31	3	-100.0%	2017-03-22, Balance as of period end
2014-12-31	96.9K	+37.5%	2016-03-15, Balance as of period end
2013-12-31	70.5K	+13.2%	2015-03-25, Balance as of period end
2012-12-31	62.3K	+19.3%	2014-03-26, Balance as of period end
2011-12-31	52.2K	+10.4%	2013-03-27, Balance as of period end
2010-12-31	47.3K	n/a	2012-03-28, Balance as of period end